LETROZOLE DEXCEL

מדינה: ישראל

שפה: אנגלית

מקור: Ministry of Health

מרכיב פעיל:

LETROZOLE

זמין מ:

DEXCEL LTD, ISRAEL

קוד ATC:

L02BG04

טופס פרצבטיות:

FILM COATED TABLETS

הרכב:

LETROZOLE 2.5 MG

מסלול נתינה (של תרופות):

PER OS

סוג מרשם:

Required

תוצרת:

HAUPT PHARMA MUNSTER GmbH, GERMANY

קבוצה תרפויטית:

LETROZOLE

איזור תרפויטי:

LETROZOLE

סממני תרפויטית:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

תאריך אישור:

2016-02-29